Switzerland-based drugs company Debiopharm Group said it would support the country’s national pre-seed fund, Venture Kick, to help business ideas at Switzerland’s institutes of higher learning and universities.
Debiopharm is the first private company to join the ranks of the five foundations – Gebert Rüf Stiftung, Ernst Gohner Stiftung, OPO-Stiftung, Avina Stiftung and Fondation 1796 des Associés de la Maison de banquiers privés Lombard Odier Darier Hentsch & Cie – in Venture Kick, which has awarded SFr8.5m ($m) since 2007…
